Airsonett AB announces that the company has appointed Anders Due-Boje as its new CEO
Airsonett AB is a medical device company with a unique technology developed to treat patients with severe asthma. The company is active in Europe, the US and recently signed a major co-operation agreement with a Chinese distributor. The company’s product Airsonett AIR-4 is a clinically validated, non-pharmaceutical treatment of asthma, which reduces allergens and other airborne irritants from the patient’s breathing zone during the nightly sleep.
Anders Due-Boje took up his position as CEO in 18 June. Anders has experience in developing both SME’s and larger corporations on a global level in the Medical Device and Information Industry and he has a strong sales and marketing focus. Anders has had leading positions within various companies, among others Neoventa Medical, GN Netcom och Motorola.
“Anders has more than 25 years’ international experience from management positions in the Medical Device and Information industry and he will be able to assist the company to take the next step in a successful development” says Magnus Lundberg, Chairman at Airsonett AB.